IP Verse

Novartis Pharmaceuticals Corporation V. Natco Pharma Limited - 1:24-cv-01033

Novartis Pharmaceuticals Corporation V. Natco Pharma Limited (Case No. 1:24-cv-01033), filed on Sep 13, 2024 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:24-cv-01033
Filing Date
Sep 13, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Novartis Pharmaceuticals Corporation -
Natco Pharma Limited -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Dec 10, 2024WAIVER OF SERVICE returned executed by Astex Therapeutics, Ltd., Novartis Pharmaceuticals Corporation: For Natco Pharma USA LLC waiver sent on 12/9/2024, answer due 2/7/2025. (Joyce, Alexandra) (Entered: 12/10/2024)PACER Document
Dec 10, 2024WAIVER OF SERVICE returned executed by Astex Therapeutics, Ltd., Novartis Pharmaceuticals Corporation: For Natco Pharma Limited waiver sent on 12/9/2024, answer due 2/7/2025. (Joyce, Alexandra) (Entered: 12/10/2024)PACER Document
Dec 10, 2024WAIVER OF SERVICE returned executed by Astex Therapeutics, Ltd., Novartis Pharmaceuticals Corporation: For Natco Pharma, Inc. waiver sent on 12/9/2024, answer due 2/7/2025. (Joyce, Alexandra) (Entered: 12/10/2024)PACER Document
Feb 3, 2025STIPULATION TO EXTEND TIME for Defendants to Answer the Complaint to through and including March 10, 2025 - filed by Natco Pharma Limited, Natco Pharma, Inc., Natco Pharma USA LLC. (Farnan, Kelly) (Entered: 02/03/2025)PACER Document
Feb 5, 2025Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Natco Pharma Limited for Natco Pharma USA LLC, Natco Pharma, Inc. filed by Natco Pharma Limited, Natco Pharma, Inc., Natco Pharma USA LLC. (Farnan, Kelly) (Entered: 02/05/2025)PACER Document
Sep 18, 2024Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb)PACER Document
Feb 4, 2025SO ORDERED, re 11 Stipulation and Order to Extend Time for Defendants to Answer the Complaint to through and including March 10, 2025. (*Reset Answer Deadlines: Natco Pharma Limited answer due 3/10/2025; Natco Pharma USA LLC answer due 3/10/2025; Natco Pharma, Inc. answer due 3/10/2025). Ordered by Judge Jennifer L. Hall on 2/4/2025. (ceg)PACER Document
Feb 4, 2025DEFICIENCY NOTICE issued by the Court to Defendants: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (ceg)PACER Document
Sep 13, 2024COMPLAINT for ANDA / PATENT INFRINGEMENT filed against Natco Pharma Limited, Natco Pharma USA LLC, and Natco Pharma, Inc. (Filing fee $ 405, receipt number ADEDC-4498137.) - filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics, Ltd. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(mws) (Entered: 09/16/2024)Attachment
Sep 13, 2024COMPLAINT for ANDA / PATENT INFRINGEMENT filed against Natco Pharma Limited, Natco Pharma USA LLC, and Natco Pharma, Inc. (Filing fee $ 405, receipt number ADEDC-4498137.) - filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics, Ltd. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(mws) (Entered: 09/16/2024)Attachment